As Transenterix INC (TRXC) Shares Rose, Shareholder Aisling Capital LLC Has Cut Stake

October 13, 2018 - By Marguerite Chambers

TransEnterix, Inc. (NYSEAMERICAN:TRXC) LogoInvestors sentiment increased to 2.15 in Q2 2018. Its up 0.51, from 1.64 in 2018Q1. It increased, as 15 investors sold TRXC shares while 18 reduced holdings. 47 funds opened positions while 24 raised stakes. 59.38 million shares or 18.11% more from 50.28 million shares in 2018Q1 were reported. Wells Fargo & Mn, California-based fund reported 120,044 shares. Comml Bank Of Montreal Can owns 85,374 shares or 0% of their US portfolio. Ledyard Natl Bank has invested 0% of its portfolio in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Moreover, Pittenger Anderson has 0% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Morgan Stanley has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Bowling Mgmt Lc, Ohio-based fund reported 20,000 shares. Artemis Investment Mngmt Llp accumulated 0.08% or 1.32M shares. Bluecrest Ltd reported 23,899 shares. One Trading Lp has 0.01% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Capstone Advsr Ltd Liability Com, a New York-based fund reported 150,000 shares. Signaturefd Ltd Com, Georgia-based fund reported 5,379 shares. Piedmont Inv Advsr Ltd Liability Co reported 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Mariner Ltd Liability Co reported 70,000 shares. Maryland has invested 0.05% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Gotham Asset Ltd owns 22,998 shares.

Since June 1, 2018, it had 0 buys, and 6 selling transactions for $7.64 million activity. $99,090 worth of TransEnterix, Inc. (NYSEAMERICAN:TRXC) shares were sold by Fernando Anthony C. J.. On Monday, June 25 the insider Pope Todd sold $1.78M.

Aisling Capital Llc decreased its stake in Transenterix Inc. (TRXC) by 35.39% based on its latest 2018Q2 regulatory filing with the SEC. Aisling Capital Llc sold 3.50 million shares as the company’s stock rose 52.10% with the market. The hedge fund held 6.39M shares of the health care company at the end of 2018Q2, valued at $27.86M, down from 9.89 million at the end of the previous reported quarter. Aisling Capital Llc who had been investing in Transenterix Inc. for a number of months, seems to be less bullish one the $1.00B market cap company. The stock decreased 1.85% or $0.09 during the last trading session, reaching $4.78. About 6.91M shares traded or 6.98% up from the average. TransEnterix, Inc. (NYSEMKT:TRXC) has risen 330.95% since October 13, 2017 and is uptrending. It has outperformed by 315.33% the S&P500.

Analysts await TransEnterix, Inc. (NYSEAMERICAN:TRXC) to report earnings on November, 8. They expect $-0.07 EPS, up 22.22 % or $0.02 from last year’s $-0.09 per share. After $-0.06 actual EPS reported by TransEnterix, Inc. for the previous quarter, Wall Street now forecasts 16.67 % negative EPS growth.

Another recent and important TransEnterix, Inc. (NYSEAMERICAN:TRXC) news was published by which published an article titled: “TransEnterix’s MST Medical Buyout to Boost Senhance Platform” on September 24, 2018.

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.